Article Details

Takeda and partners halt development of COVID-19 plasma therapy

Retrieved on: 2021-04-06 15:22:30

Tags for this article:

Click the tags to see associated articles and topics

Takeda and partners halt development of COVID-19 plasma therapy. View article details on hiswai:

Excerpt

But the plasma treatment, administered in combination with the antiviral drug remdesivir, failed to show greater efficacy in preventing more serious ...

Article found on: asia.nikkei.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up